Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)

Clinical trial NCT04160546 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04160546
Sponsor: Fundacion CRIS de Investigación para Vencer el Cáncer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia, Chronic Phase

Start date: 2020-01-17
Primary completion: 2025-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.